Prophylaxis of CMV disease by ganciclovir (DHPG) in seronegative recipients of renal allograft from seropositive donors

  • E. Rondeau
  • M. N. Peraldi
  • J. D. Sraer
  • B. Bourgeon
  • Ph. Lang
  • C. Buisson
  • K. M. Schulte
  • B. Weill
Conference paper

Abstract

In an open-label randomized study of prophylactic treatment by ganciclovir, 23 seronegative recipients of kidney allograft from seropositive donors were randomized to receive from day 14 to day 28 after transplantation either no treatment (n = 11) or ganciclovir, 5 mg/kg twice daily (n = 12). Both groups were similar in age, immunosuppressive therapy, number of acute rejections and in steroid bolus. Seroconversion occurred in ten patients of the control group (91%) and in ten of the ganciclovir group (84%). CMV disease occurred in ten patients of the control group (91%) and in eight patients of the ganciclovir group (66%), three of whom had asymptomatic viraemia. The delay between transplantation and onset of CMV disease was significantly increased by ganciclovir prophylaxis (78.5 ± 7.7 vs 46.5 ±7.5 days, P < 0.05). We conclude that in renal transplant recipients at risk of CMV disease, ganciclovir prophylaxis delays the onset of the disease and seems to decrease its incidence and its severity.

Key words

Cytomegalovirus Ganciclovir Prophylaxis Renal Transplantation 

References

  1. 1.
    Balfour HH, Chace BA, Stapleton JT, Simmons RL, Fryd DS (1989) A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320:1381–1387PubMedCrossRefGoogle Scholar
  2. 2.
    Bowden RA, Sayers, M, Flournoy N, Newton B, Banaji M, Thomas D, Meyers JD (1986) Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med 314:1006–1010PubMedCrossRefGoogle Scholar
  3. 3.
    Keay S, Petersen E, Icenogle T, Zeluff BJ, Samo T, Busch D, New Man CL, Buhles WC, Merigan TC (1988) Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients. Rev Infect Dis 10: S563-S572PubMedCrossRefGoogle Scholar
  4. 4.
    Rondeau E, Farquet C, Ruedin P, Fries D, Sraer JD (1990) Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients. Transplant Proc 22: 1813- 1814PubMedGoogle Scholar
  5. 5.
    Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia J A (1991) A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324: 1005–1011PubMedCrossRefGoogle Scholar
  6. 6.
    Snydman DR, Werner BG, Heinze-Lacey B, Berardi VP, Tilney NL, Kirkman RL, Milford EL, Cho SI, Bush HL, Levey AS, Strom TB, Carpenter CB, Levey RH, Harmon WE, Zimmerman CE, Shapiro ME, Steinman T, Logerfo F, Idelson B, Schroter GPJ, Levin MJ, Mclver J, Leszczynski J, Grady GF (1987) Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 317:1049–1054PubMedCrossRefGoogle Scholar
  7. 7.
    Tyms AS, Davis JM, Jeffries D J, Meyers JD (1984) BWB759U, an analogue of acyclovir, inhibits human cytomegalovirus in vitro. Lancet ii: 924–925Google Scholar
  8. 8.
    Weir MR, Irwin BC, Maters AW, Genemans G, Shen SY, Charache P, Williams GM (1987) Incidence of cytomegalovirus disease in cyclosporine-treated renal transplant recipients based on donor/recipient pretransplant immunity. Transplantation 43: 187–193PubMedCrossRefGoogle Scholar
  9. 9.
    Weir MR, Henry ML, Blackmore M, Smith J, First MR, Irwin B, Shen S, Genemans G, Alexander JW, Corry RJ (1988) Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. Transplantation 45: 111–116PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • E. Rondeau
    • 1
  • M. N. Peraldi
    • 1
  • J. D. Sraer
    • 1
  • B. Bourgeon
    • 2
  • Ph. Lang
    • 2
  • C. Buisson
    • 2
  • K. M. Schulte
    • 2
  • B. Weill
    • 2
  1. 1.Service de NéphrologieHôpital TenonParisFrance
  2. 2.Service de NéphrologieHôpital Henri MondorCréteilFrance

Personalised recommendations